The cannabis industry in Canada has experienced unprecedented growth since the Cannabis Act came into effect in 2018. It is widely expected that cannabidiol (CBD) will be classified as a food and natural health ingredient in Canada, the European Union, and other jurisdictions in the near future, which will open up a significant market. In 2023, Dr. Jacqueline Shan, the CEO of PBG BioPharma, made a long-term strategic decision to enter the cannabis consumer health market by launching a series of CBD consumer health products once the cannabis regulations in Canada are relaxed. In preparing to launch its own consumer product line, PBG BioPharma is developing its marketing strategy and analyzing potential challenges in managing its supply chain.

In 2014, Shenzhen Bauing Construction Holding Group Co. Ltd. (Bauing Group) decided to expand internationally, and successfully established subsidiary companies in several Southeast Asian countries. Based on this success in Southeast Asia, Bauing Group decided in 2016 to expand further by entering the US market. However, doing so entailed some challenges and difficulties, including cultural and regional differences, language barriers, and the need to become familiar with different construction standards and laws. Bauing Group also needed to address a pressing issue: determining its market entry strategy. Should it enter the market through licensing, greenfield projects, franchising, business alliances, exporting, turnkey projects, joint ventures, or acquisitions?